In a study by Kim et al. on three different types of tumor cell lines, including the colon cancer cell line SW480, treatment with siRNA against AKT1 before irradiation reduced cell survival more than siRNA treatment against AKT2 or AKT3 [29]. This evidence concerns the gene AKT2 and malignant colon neoplasm.